Global Market Estimates Strategic Insights - Beating The Pandemic's
Effect On Your Revenues
Global Hematology Analyzers and Reagents Market Size, Trends & Analysis - Forecasts To 2026 By Product (Instruments, Consumables), By End Use (Stand-alone hospitals, Commercial Organizations, Clinical Testing Labs, Research Institutes), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis
Hematology Analyzers And Reagents Market: Insights
The global hematology analyzers and reagents market is estimated to witness a significant CAGR during the forecast period (2020-2026). Hematology is the medical branch which deals with the study, diagnosis, and treatment of blood-related disorders. The growth of the market is anticipated to increase due to the growing demand for high-throughput hematology analyzers and high sensitivity point-of-care (POC) testing. Moreover, growing technological advancements and the introduction of basic flow-cytometry techniques analyzers are some of the significant factors propelling the market growth. However, high costs of hematology analyzers are likely to hamper the market growth during the forecast period.
Hematology Analyzers And Reagents Market: By Product
Based on product, the global hematology analyzers and reagents market is segmented into instruments, and consumables. Analyzers are highly specialized computers that help to determine the blood sample count, presence, and different types of cellular elements.
Hematology Analyzers And Reagents Market: By End Use
Based on end-use, the global hematology analyzers and reagents market is segmented into stand-alone hospitals, clinical testing labs, research institutes, and commercial organizations. The clinical testing labs segmented is expected to hold the largest market share during the forecast period due to the growing prevalence of blood related disorders such as hereditary spherocytosis, and chronic granulomatous disease, among others.
Hematology Analyzers And Reagents Market: By Region
Based on region, the global hematology analyzers and reagents market is segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. North America is expected to witness considerable growth in the hematology analyzers and reagents market during the forecast period. Rising adoption of automated hematology instruments by diagnostic laboratories is one of the significant factors driving the market growth. The Asia-Pacific region is expected to grow at a high CAGR in terms of revenue during the forecast period. Development of health care facilities, increased incidence of blood and blood associated diseases such as cancer in emerging countries including India, Japan, South Korea, China, and Singapore, among others coupled with innovation in the manufacturing of hematology analyzers and reagents are propelling the market growth in the region.
Hematology Analyzers And Reagents Market: Share & Competitor Analysis
Some of the key players operating in the hematology analyzers and reagents market are Beckman Coulter, Sysmex Corporation, HORIBA Ltd, Abbott Laboratories, Bio-Rad Laboratories, Siemens AG, Mindray Medical International Limited, Boule Diagnostics AB, Roche Diagnostics, and Nihon Kohden Corporation, among others.
In January 2020, Abbott Laboratories invented Heart valve in Roseville which allows replacement of mitral valve without invasive open-chest surgery
In January 2020, Siemens Healthineers signed a strategic agreement with Hamilton Health Sciences for 15 years for USD 270 million Canadian Dollars to enhance imaging services
Related Report: Global Hematology Analyzers Market Size, Trends & Analysis - Forecasts to 2026
Check the Press Release on Global Hematology Analyzers and Reagents Market Report
Hematology Analyzers and Reagents Market: By Product
Hematology Analyzers and Reagents Market: By End Use
Hematology Analyzers and Reagents Market: By Region
The global Hematology Analyzers and Reagents Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Hematology Analyzers and Reagents Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
A dedicated client engagement team for round the clock support in terms of requirement gathering, query handling, and any other support activity.
More than 50% of innovation comes from the voice of the customer through which our analysts find blindspots in your revenue decisions.
The best vision is actionable insights across high growth markets with GMEs disruptive research methodology.
Disruptive research that correlates markets, technologies, new use cases and companies.
80% of Fortune 2000 use GME for their growth strategies.
Get in-depth analysis of the COVID-19 impact on this study
Benchmarking the rapid strategy shifts of the Top 100 companies in this market space
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
